person

Helle P.

Country
Denmark
Department
Urooncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
64
Sites with multiple studies

Has run more than one trial at 64 of 226 partner sites.

Specializations

Urothelial Cancer Management

The investigator specializes in treating various stages of urothelial carcinoma, with particular expertise in both localized and metastatic disease states. Their research encompasses novel approaches for bladder cancer treatment, including post-surgical monitoring and therapeutic interventions.

  • Metastatic Disease Management
  • Post-Radical Cystectomy Care
  • Advanced Urothelial Carcinoma

Their work includes innovative monitoring techniques using circulating tumor DNA for early detection of disease recurrence.

Immunotherapy Applications

The investigator focuses on advancing immunotherapeutic approaches in urological cancers, particularly exploring the role of PD-1/PD-L1 targeted agents. Their research includes both single-agent and combination therapy strategies.

  • Novel Immunotherapy Combinations
  • Treatment-Resistant Disease
  • Biomarker-Driven Therapies

A key area of focus is developing treatments for patients with PD-1/L1 refractory disease.

Prostate Cancer Research

The investigator conducts research in metastatic castration-resistant prostate cancer, exploring innovative combination therapies. Their work includes investigation of novel drug combinations with established treatments.

  • Treatment-Resistant Disease
  • Biomarker Studies
  • Combination Therapy Approaches

Their research includes evaluation of biochemical response markers in prostate cancer treatment.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.